Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Status:
Terminated
Trial end date:
2019-05-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether it is better to receive the drug Metformin with
standard of care for lung cancer or just standard of care.